New Study — CTN 302: Visioning Health II
Enhancing HIV-Positive Aboriginal Women’s health through culturally-grounded and arts-informed research Health is more than just...
Learn MoreNovember 22, 2016
So what about the gut?
The advent of combination antiretroviral therapy (cART) has greatly changed the way people live with...
Learn More
Study demonstrates the acceptability of HIV point-of-care testing in inner-city emergency department
A collaborative group of scientists in Vancouver have published results from a study showing the...
Learn More
HPV vaccine safe for HIV+ girls and women: CTN 236
The safety and potential efficacy of vaccination against the human papillomavirus (HPV) in HIV-positive women...
Learn More
Turning to PrEP for Prevention
February saw a possible turning point in the prevention of HIV, when Health Canada approved Truvada...
Learn More
Seeking a Reprieve for Heart Disease: CTN Partners with the ACTG
The REPRIEVE trial (A5332, CTN 293 – Randomized Trial to Prevent Vascular Events in HIV)...
Learn More
TriiAdd study looks to improve adherence with a single pill per day
The TriiAdd study (CTN 286) will test to see if using a new single tablet...
Learn More
ANRS IPERGAY Study (CTN 268) Update
The results of Phase I of the ANRS IPERGAY trial (CTN 268) are very promising,...
Learn More
A breakthrough in HIV prevention
Early data from the CTN 268 – ANRS IPERGAY trial validates ‘on demand’ pre-exposure prophylaxis...
Learn More